Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma

BACKGROUND: Glypican-3 (GPC3), a cell surface glycoprotein that is pathologically highly expressed in hepatocellular carcinoma (HCC), is an attractive target for immunotherapies, including chimeric antigen receptor (CAR) T cells. The serum GPC3 is frequently elevated in HCC patients due to the shedd...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Luan, Gao, Fang, Gao, Zhanhui, Ao, Lei, Li, Na, Ma, Sujuan, Jia, Meng, Li, Nan, Lu, Peihua, Sun, Beicheng, Ho, Mitchell, Jia, Shaochang, Ding, Tong, Gao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039282/
https://www.ncbi.nlm.nih.gov/pubmed/33833049
http://dx.doi.org/10.1136/jitc-2020-001875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039282/
https://www.ncbi.nlm.nih.gov/pubmed/33833049
http://dx.doi.org/10.1136/jitc-2020-001875

Ejemplares similares